ID: PMRREP3037
Format: PPT*, PDF, EXCEL
Last Updated: 1 Sep 2025
Industry: Healthcare
Number of Pages: 199
The global pharmaceutical packaging equipment market size is likely to be valued at US$ 9.7 Bn in 2025 and estimated at US$ 16.1 Bn by 2032 growing at CAGR of 7.5% during forecast period 2025-2032.
Pharmaceutical packaging equipment is a critical segment of the pharmaceutical industry, driven by demand for pharma machinery, blister packaging, and cartoning machines to ensure safe, efficient, and compliant packaging solutions. The market growth benefits from expanding pharmaceutical production, growth in generics, and the rise of personalized medicine, pushing manufacturers to invest in high-speed, flexible, and sustainable packaging solutions.
Key Industry Highlights:
Global Market Attribute |
Key Insights |
Pharmaceutical Packaging Equipment Market Size (2025E) |
US$ 9.7 Bn |
Market Value Forecast (2032F) |
US$ 16.1 Bn |
Projected Growth (CAGR 2025 to 2032) |
7.5% |
Historical Market Growth (CAGR 2019 to 2024) |
6.8% |
The pharmaceutical packaging equipment market is propelled by the rising global pharmaceutical production and stringent regulatory requirements, driving demand for pharma machinery, blister packaging, and cartoning machines. In 2025, global pharmaceutical sales reached US$ 1.48 Tn, with a 5.8% annual growth rate, boosting demand for high-speed pharmaceutical cartoning equipment and sterile packaging equipment by 20%.
Regulatory bodies such as the FDA and EMA mandate serialization in pharma packaging and track and trace technology in pharma, with 90% of U.S. pharmaceutical products requiring serialization in 2025, increasing adoption of pharmaceutical labeling machines by 25%. The rise in chronic diseases, affecting 60% of adults globally, drives liquid filling systems and aseptic packaging equipment for syrup and aerosol applications, with 15% growth in 2025. Marchesini Group reported 12% revenue growth in 2025 from pharma packaging technology, driven by medical packaging systems. The global push for cold chain packaging solutions, with US$ 20 Bn in investments by 2025, supports smart pharma packaging for biologics, positioning the market for sustained growth across tablets and powders applications.
The pharmaceutical packaging equipment market faces challenges due to high initial investment and maintenance costs for healthcare packaging machinery and aseptic packaging equipment. Installing high-speed pharmaceutical cartoning equipment and liquid filling systems costs between US$ 500,000 and US$ 2 Mn per unit, limiting adoption by small and medium-sized enterprises (SMEs). Maintenance costs, requiring 15% of equipment value annually, impact pharma blister packaging machinery suppliers and secondary packaging solutions, increasing operational expenses by 20%.
Regulatory compliance for serialization in pharma packaging and track and trace technology in pharma adds 10% to setup costs, particularly affecting pharmaceutical labeling machines. These constraints slow market expansion in emerging regions, where 30% of manufacturers face budget limitations, impacting manual and semi-automatic equipment adoption.
Advancements in sustainable pharmaceutical packaging solutions and smart pharma packaging present significant opportunities for the pharmaceutical packaging equipment market, driving demand for medical packaging systems and cold chain packaging solutions. In 2025, the global sustainable packaging market reached US$ 280 Bn, with a 6.5% CAGR, boosting blister packaging and cartoning machines with eco-friendly materials by 15%.
Smart pharma packaging, integrating IoT and RFID for track and trace technology in pharma, saw 20% adoption in 2025, enhancing pharmaceutical labeling machines for real-time monitoring. Emerging markets, with US$ 50 Bn in pharmaceutical infrastructure investments, offer potential for aseptic packaging equipment and secondary packaging solutions, particularly for aerosol and cream applications. Uhlmann Group reported 10% growth in 2025 from sustainable pharmaceutical packaging solutions, positioning the market for expansion in tablets and syrup segments.
Automatic equipment holds a 50% market share in 2025, driven by high-speed pharmaceutical cartoning equipment. It supports pharma packaging technology for high-volume production. Equipped with advanced features such as robotics, real-time monitoring, and serialization integration, these machines support the pharmaceutical industry's growing need for track and trace technology and tamper-proof solutions. Additionally, automatic equipment contributes to labor cost reduction and improved operational efficiency, making it the preferred choice for large pharmaceutical manufacturers.
Semi-automatic equipment fueled by healthcare packaging machinery for SMEs. It offers flexibility for sterile packaging equipment in tablets and powders applications. These machines allow operators to maintain oversight of critical steps while still benefiting from automation in repetitive tasks, striking a balance between efficiency and affordability. With increasing adoption among emerging market manufacturers and niche pharmaceutical players, semi-automatic equipment remains an attractive choice for businesses aiming to achieve compliance and productivity without significant capital expenditure.
Tablets application commands a 35% market share in 2025, driven by sterile packaging equipment. it relies on blister packaging and pharmaceutical labeling machines for high-volume production. pharmaceutical labeling machines with track and trace capabilities play a crucial role in enabling serialization, ensuring compliance with global regulations such as DSCSA and EU FMD. The adoption of digital printing and smart labels further enhances patient safety and authenticity. The growing demand for generic drugs, coupled with cost-effective, high-speed production systems, continues to fuel the growth of this segment.
Aerosol application is fueled by aseptic packaging equipment. It supports healthcare packaging machinery for respiratory drugs. The growing prevalence of chronic respiratory diseases, combined with innovations in inhalation devices and the expansion of biologics requiring specialized aerosol packaging, positions this segment for strong growth. Manufacturers are increasingly focusing on sustainable propellants and eco-friendly aerosol systems to align with environmental guidelines, adding another layer of innovation to this market.
Blister Packaging holds a 30% market share in 2025, driven by pharma blister packaging machinery suppliers. It supports sterile packaging equipment for tablets. Blister packs offer tamper-proof and moisture-resistant barriers, which are essential for patient safety and regulatory compliance, further strengthening their adoption in both prescription and OTC drug markets.
Labelling is fueled by pharmaceutical labeling machines and track and trace technology in pharma. it supports serialization in pharma packaging. These technologies not only enhance brand protection and patient safety but also facilitate real-time monitoring and digital authentication of products throughout the distribution network. The increasing push toward smart labeling solutions and digital printing for customization further accelerates this segment’s growth.
North America holds a 40% global market share in 2025, valued at US$ 3.88 Bn, with the U.S. leading due to advanced pharmaceutical infrastructure. The U.S. market, driven by track and trace technology in pharma and serialization in pharma packaging. In 2025, 50% of U.S. pharmaceutical companies adopted pharmaceutical labeling machines, supported by FDA’s Drug Supply Chain Security Act (DSCSA), increasing smart pharma packaging adoption by 25%.
The rise in biologics, with US$ 150 Bn in sales, boosts cold chain packaging solutions and aseptic packaging equipment. Körber AG holds a 15% regional share, leveraging pharma packaging technology for tablets and syrup. Investments in healthcare packaging machinery, reaching US$ 10 Bn by 2025, drive sustainable pharmaceutical packaging solutions in blister packaging.
Europe accounts for a 30% global share, valued at US$ 2.91 Bn in 2025, led by Germany, the UK, and France, driven by stringent regulations and pharmaceutical innovation. Germany’s market generating US$ 1.16 Bn, propelled by pharma blister packaging machinery suppliers and sterile packaging equipment.
The pharmaceutical sector, contributing €300 Bn to the economy, saw 40% of manufacturers adopt high-speed pharmaceutical cartoning equipment in 2025, driven by EU GMP regulations. The UK market, is driven by pharmaceutical labeling machines, with 35% adoption for serialization in pharma packaging. France’s market grows at 8%, fueled by cold chain packaging solutions, with €200 Mn in biologics investments. Uhlmann Group leads with secondary packaging solutions, capturing 12% of the market.
Asia Pacific is the fastest-growing region, with a CAGR of 8.2%, valued at US$ 2.91 Bn in 2025, led by China, Japan, and India, driven by pharmaceutical production and generics growth. China holds a 50% regional share, generating US$ 1.46 Bn in 2025, fueled by US$ 50 Bn in pharma investments, boosting healthcare packaging machinery and liquid filling systems. In 2025, 45% of Chinese manufacturers adopted aseptic packaging equipment.
India’s pharmaceutical packaging market is driven by 30% growth in generics, with 40% adoption of pharma blister packaging machinery suppliers. Japan’s market sees 10% growth, with 35% adoption of pharmaceutical labeling machines for biologics. ACG Worldwide captures 10% of the regional market with smart pharma packaging.
The global pharmaceutical packaging equipment market is highly competitive, with Marchesini Group, Körber AG, I.M.A. Industria Macchine Automatiche S.p.A., Uhlmann Group, Accutek Packaging Equipment Companies, Bausch + Ströbel, Coesia, Vanguard Pharmaceuticals Equipment, MULTIVAC Group, OPTIMA Packaging Group, ACG Worldwide, and Brevetti CEA S.p.A. focusing on pharma machinery, blister packaging, and cartoning machines.
Companies leverage serialization in pharma packaging and track and trace technology in pharma to gain market share. Strategic R&D investments in sustainable pharmaceutical packaging solutions and partnerships drive healthcare packaging machinery, addressing smart pharma packaging needs.
The pharmaceutical packaging equipment market is projected to reach US$ 9.7 Bn in 2025, driven by pharma machinery and blister packaging.
Global pharmaceutical sales of US$ 1.48 Tn in 2025 and stringent regulations fuel serialization in pharma packaging.
The market grows at a CAGR of 7.5% from 2025 to 2032, reaching US$ 16.1 Bn by 2032.
Advancements in sustainable pharmaceutical packaging solutions and smart pharma packaging, with 20% IoT adoption, offer growth potential.
Key players include Marchesini Group, Körber AG, Uhlmann Group, I.M.A., and ACG Worldwide.
Report Attribute |
Details |
Historical Data/Actuals |
2019 - 2024 |
Forecast Period |
2025 - 2032 |
Market Analysis Units |
Value: US$ Bn, Volume: As Applicable |
Geographical Coverage |
|
Segmental Coverage |
|
Competitive Analysis |
|
Report Highlights |
|
Customization and Pricing |
Available upon request |
By Automation
By Application
By Machine Type
By Region
For more information on this report and its delivery timelines please get in touch with our sales team.
About Author